JOINT BASE SAN ANTONIO-FORT SAM HOUSTON, Texas (Aug. 7, 2020) -- Brooke Army Medical Center is expanding its use of a highly specialized treatment many consider the “last line of defense” for critically ill COVID-19 patients.
Extracorporeal membrane oxygenation, or ECMO, is a heart-lung bypass intervention that is proving to be lifesaving for some patients with COVID-19.
“ECMO is often the last line of defense for the most critically ill patients with severe pulmonary disease,” said Air Force Col. Patrick Osborn, BAMC’s Deputy Commander for Surgical Services. “Whether due to COVID-19 or another condition, ECMO provides a life-support option that can potentially save lives when all other options are exhausted.”
BAMC, one of the few local facilities that offer the treatment, is currently providing up to one-third of the ECMO capability for the San Antonio area’s most severely ill community members, veterans and military beneficiaries suffering from the virus.
“As much as able, BAMC is easing the burden on local healthcare resources by admitting civilian ECMO patients,” Osborn said.
This treatment, which requires a multidisciplinary team of specially trained medical personnel, is used in the intensive care unit when a patient experiences heart and/or lung failure. The ECMO machine removes blood from central vessels in a patient’s body, circulates it through an artificial lung, oxygenates it, and delivers the blood back into the bloodstream. In essence, it replaces the natural functions of the heart and lungs while treatments and natural healing of the affected organs take place.
“ECMO is not a treatment for any specific disease. It works by keeping critically ill patients alive and buying time for us to address their underlying condition,” explained Air Force Col. Phillip Mason, Medical Director for BAMC’s Adult ECMO program. “In some cases, we can reduce a patient's chance of dying from 80 to 90 percent down to 30 to 40 percent. While 30 to 40 percent is still high, it represents a significant improvement and translates into many lives saved.”
Established in October 2012, BAMC has the only adult ECMO center in the Department of Defense and remains one of the few centers with global air transportable ECMO capability. The multi-service ECMO team has traveled as far as Iraq and Afghanistan to pick up service members in need of the treatment.
While taking care of military beneficiaries is BAMC’s primary mission, the organization is able to support civilian ECMO patients through a special Department of Defense program. The experience gained ensures the ECMO team sustains the skills required to mobilize worldwide to treat and transport patients back to BAMC, Osborn said.
Pre-COVID, BAMC typically had up to four ECMO patients at any given time due to the highly specialized personnel, training and equipment required to care for patients. In recent weeks, the hospital has expanded its capability and is treating up to nine patients at one time, most who are battling COVID-19.
An ECMO team carefully considers the treatment after other lifesaving measures, such as oxygen therapy or a ventilator, have been exhausted.
“The vast majority of the critical care community believes that ECMO is effective as a rescue therapy for respiratory failure that does not respond to conventional therapies,” Mason noted.
BAMC is part of a multinational observational trial of ECMO’s use for COVID-19 that should help to reveal evidence-based proof of the treatment’s effectiveness, but that’s further down the line, Mason said.
“While COVID is a complex disease effecting many organ systems, its primary manifestation is respiratory failure so there is at least some reason to believe ECMO will be effective,” he said, noting the treatment is often used for other viral respiratory illnesses, such as influenza.
With the program in place for nearly a decade, BAMC’s COVID team is accustomed to working closely with local hospitals in the event a patient may be a candidate for ECMO. This collaboration has stepped up in recent months, creating a larger influx of patients.
To expand capacity to meet the growing community need, BAMC called on its ECMO team to train additional nurses and technicians on the equipment, while also leaning on personnel from the U.S. Army Institute of Surgical Research Burn Center, which is housed in the hospital, to assist.
“With the support of the ISR we have been able to expand our ECMO capacity significantly,” said Army Maj. Michal Sobieszczyk, Staff Physician, Interventional Pulmonology and Critical Care Medicine. "The BAMC and ISR bedside nurses have been instrumental in making the ECMO mission a success"
ECMO may be a last resort for COVID patients, but one that has proved lifesaving for many.
Sobieszczyk recalled one recent patient in his late 20s who was placed on ECMO two times, once for COVID-19 pneumonia, from which he recovered, and the second time for a bacterial pneumonia and sepsis.
“He required a high level of support and came close to dying several times,” Sobieszczyk said. “Fortunately, he was able to be weaned off ECMO and was decannulated (tubes removed) earlier this week.”
As a last-resort measure, ECMO is a high-stakes endeavor, Mason noted. “We have the highest highs and the lowest lows. But each life saved is incredibly rewarding for us, and a testament to the importance of this treatment.”
ECMO is just one of the lines of defense against COVID-19, but one that BAMC is proud to offer to its beneficiaries and the community, Sobieszczyk said.